Raffaele Bugiardini

Professor of Cardiology

University of Bologna

Italy

Research Interests

Explore related searches

Professors in Italy

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Raffaele Bugiardini is a Professor of Cardiology at the University of Bologna, Italy. His research focuses on cardiovascular health disparities, oncological drug cardiotoxicity, and ischemic heart disease. He has contributed extensively to understanding inequalities in cardiovascular outcomes and has published influential articles addressing traditional risk factors and sex differences in health. Professor Bugiardini is dedicated to tackling cardiovascular health inequalities and advancing knowledge in the field.

Articles (16)

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2021

Year:

2020

Year:

2020

Year:

2020

Collaborators (4)

Geneviève A Derumeaux

FRANCE

View details

Cor de Wit

University of Lübeck

GERMANY

View details

Olivia Manfrini

University of Bologna

ITALY

View details

Etto Eringa

Associate Professor

University of Maastricht

NETHERLANDS

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Raffaele Bugiardini

Research Interests

Explore related searches

Contact this professor

About

Articles (16)

Introducing The Lancet Regional Health-Europe commission on inequalities and disparities in cardiovascular health

Anticancer-Drug-Related Cardiotoxicity from Adjuvant Goserelin and Tamoxifen Therapy

Announcing The Lancet Regional Health-Europe commission on inequalities and disparities in cardiovascular health

Closing the sex gap in cardiovascular mortality by achieving both horizontal and vertical equity

Traditional risk factors and premature acute coronary syndromes in South Eastern Europe: a multinational cohort study

Sex differences and disparities in cardiovascular outcomes of COVID-19

MicroRNAs as Potential Biomarkers in Coronary Artery Disease

Combined Therapy with Anthracyclines and GnRH Analogues for Breast Cancer: Impact on Ischemic Heart Disease

Clinical determinants of ischemic heart disease in Eastern Europe

Tackling cardiovascular health inequalities in European countries

Concerns about the use of digoxin in acute coronary syndromes

The Role of Vasospasm and Microcirculatory Dysfunction in Fluoropyrimidine-Induced Ischemic Heart Disease

Cardiovascular disease and COVID-19: a consensus paper from the ESC Working Group on Coronary Pathophysiology & Microcirculation, ESC Working Group on Thrombosis and the Association for Acute CardioVascular Care (ACVC), in collaboration with the European Heart Rhythm Association (EHRA)

Gender Differences in Residual Risk Factors for Major Adverse Cardiovascular Events Following ACS and How to Bridge the Gap

Aspirin for primary prevention of ST segment elevation myocardial infarction in persons with diabetes and multiple risk factors

Prior Beta-Blocker Therapy for Hypertension and Sex-Based Differences in Heart Failure Among Patients With Incident Coronary Heart Disease

Collaborators (4)

Geneviève A Derumeaux

Cor de Wit

Olivia Manfrini

Etto Eringa

Make your next move.